重大事件
即時報告
8-K
2026-08-07
OSR Health發8-K澄清Nasdaq未批准股東忠誠CVR計劃 紀錄日期維持8月14日
AI 繁中摘要
8-K｜OSR Health就Nasdaq先前通訊及股東忠誠CVR計劃發出澄清 📋
OSR Health, Inc.（NASDAQ: OSRH）於2026年8月7日發表新聞稿，就早前7月31日有關Nasdaq及公司股東忠誠CVR計劃的公告作出澄清。公司明確表示，先前公告中「該通訊確認我們的忠誠計劃具增值性，並為股東提供清晰度」的陳述，不應被理解為Nasdaq已批准或背書該股東忠誠CVR計劃。
公司解釋，Nasdaq早前的通訊僅屬初步口頭意見，範圍僅限於技術性問題，即該計劃會否導致OSRH普通股股價出現機械式調整（例如除息日調整）。除此以外，Nasdaq並未就計劃發表任何明確立場。是次澄清不會影響公司已公佈的股東忠誠CVR計劃紀錄日期，即2026年8月14日。計劃詳情、合資格條件及登記資料，仍可於 www.osr-health.com/loyaltyprogram 查閱。公司表示會繼續適時向股東更新進展。
OSR Health是一家總部位於華盛頓州貝爾維尤的全球醫療保健控股公司，旗下業務涵蓋免疫腫瘤學、再生生物製劑及醫療設備技術，旨在推動健康與保健領域的生物醫學創新，改善全球醫療成效。
分析指出，是次澄清對投資者的潛在影響在於消除市場對Nasdaq立場的誤解。雖然計劃的紀錄日期維持不變，但公司仍面對多項不確定性，包括待處理的SEC不採取行動請求、Nasdaq對計劃的最終取態、計劃持有期及股價條件是否獲滿足，以及公司能否繼續維持在Nasdaq上市等。實際結果可能與前瞻性陳述存在重大差異，投資者應審慎評估相關風險。
展開英文正文
EX-99.1 2 ea030111401ex99-1.htm PRESS RELEASE, DATED AUGUST 7, 2026, TITLED "OSR HEALTH ISSUES CLARIFICATION REGARDING PRIOR NASDAQ COMMUNICATION AND SHAREHOLDER LOYALTY CVR PROGRAM" Exhibit 99.1 OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program BELLEVUE, WA / ACCESS Newswire / August 7, 2026 / OSR Health, Inc. (NASDAQ: OSRH) (“OSR Health” or the “Company”) today issued a clarification regarding its press release dated July 31, 2026 concerning the Nasdaq Stock Market (“Nasdaq”) and the Company’s Shareholder Loyalty CVR Program. The Company is clarifying that the statement in the prior release, “The communication affirms that our loyalty program is additive and gives shareholders clarity,” should not be interpreted as indicating that Nasdaq has approved or endorsed the Shareholder Loyalty CVR Program. Nasdaq’s earlier communication was a preliminary, verbal indication limited to the technical question of whether the program would result in a mechanical adjustment to the price of OSRH common stock (such as an ex-date adjustment). Other than that, Nasdaq has not expressed any definitive opinion regarding the program. This clarification does not change the Company’s previously announced August 14, 2026 record date for the Shareholder Loyalty CVR Program. Program details, eligibility, and enrollment information remain available at www.osr-health.com/loyaltyprogram. The Company will update shareholders as matters progress. About OSR Health OSR Health, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Health engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.osr-health.com Investor Contact OSR Health, Inc. Investor Relations [email protected] Forward-Looking Statements This press release contains forward-looking statements, including statements regarding the Shareholder Loyalty CVR Program and the Company’s regulatory and securities-law processes. These statements are subject to risks and uncertainties, including the outcome and timing of the Company’s pending SEC no-action request, Nasdaq’s ultimate position on the program, the satisfaction of the program’s holding-period and price conditions, the Company’s continued listing on Nasdaq, and other factors described in the Company’s SEC filings. Actual results may differ materially. The Company undertakes no obligation to update any forward-looking statement except as required by law. This release does not constitute an offer to sell or a solicitation to buy any securities.